TiumBio Co., Ltd.

₩3,500As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:321550Healthcare
Country South Korea
PE (Fwd) •••
TSR 7Y CAGR (20.47%)
Div yield —
ROE (36.65%)
Biological Products, Except Diagnostic Substances
Beta (5Y) (0.39)
PE TTM —
TSR TTM (48.76%)
Mkt cap ₩105.1B
ROIC (12.11%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩3,868
10.52%
(46.13%)
Hold 7|7|10|8|1
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
72.55
79.65
87.19
89.69
26.13%
27.02%
32.90%
33.17%
Revenue₩B
4.920
4.932
4.850
4.879
(0.36%)
(0.78%)
(0.50%)
(0.77%)
Peers (US$77.51M)
Cap (US$)
PE
83.39M
—
73.82M
5.962x
79.59M
—
Capital
TTM
5Y
10Y
Leveragex
0.085
0.784
0.512
EBIT/Intx
0.300
0.443
0.383
Own earn%
(37.77)
4.26
28.77
Sh yield%
30.41
26.18
30.31
Owners
Insiders/Inst%
7.15
62.10
Short interest%
4.67
SBC / revenue%
4.54
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
23–37
$1 testx
0.1
Incr. ROIC%
12